Medication rule of Chinese materia medica in treatment of pulmonary fibrosis based on data mining
10.7501/j.issn.0253-2670.2020.06.005
- Author:
Lin-Na MA
1
Author Information
1. Henan University of Chinese Medicine
- Publication Type:Journal Article
- Keywords:
Astragali Radix;
Chinese materia medica (CMM);
Data mining;
Glycyrrhizae Radix et Rhizoma;
Novel coronavirus pneumonia;
Pulmonary fibrosis;
Salviae Miltiorrhizae Radix et Rhizoma
- From:
Chinese Traditional and Herbal Drugs
2020;51(6):1406-1411
- CountryChina
- Language:Chinese
-
Abstract:
To explore the medication rule of Chinese materia medica (CMM) in the treatment of pulmonary fibrosis, and provide reference for the prevention and treatment of pulmonary fibrosis in the novel coronavirus pneumonia. Using Excel 2013 and SPSS Statistics 23.0, the literatures with the theme of “pulmonary fibrosis” that met the screening criteria were searched, and the association rule analysis was carried out. Frequency analysis showed that the occurrence frequency of Astragali Radix (148, 45.82%), Glycyrrhizae Radix et Rhizoma (124, 38.39%) and Salviae Miltiorrhizae Radix et Rhizoma (102, 31.58%) was the highest in the clinical treatment literature. In the statistics of nature and flavor, warm (10 times, 50.00%) and neutral (six times, 30.00%) were the most common. The highest frequency of meridian tropism was found in the spleen (11 times, 25.58%), lung (10 times, 23.26%) and sweet (11 times, 36.67%). In the analysis of association rules, six groups of TCM combinations with high frequency correlation strength were obtained. The high frequency and high correlation CMM combinations obtained from this data analysis were mainly effective in strengthening the spleen and invigorating qi, and warming the spleen and lung, which can be used to prevent the early patients from developing to the critical stage and prevent the patients from reinfection due to low immunity in the convalescence stage.
